Five-day infusion fluorouracil plus vinorelbine in women with breast cancer previously treated with anthracyclines and paclitaxel.
- 1 July 2000
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 62 (2) , 135-139
- https://doi.org/10.1023/a:1006445713773
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine.Journal of Clinical Oncology, 1998
- Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer.Journal of Clinical Oncology, 1998
- Phase I–II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: A regimen with a low subjective toxic burdenAnnals of Oncology, 1997
- Vinorelbine: An active, non cross-resistant drug in advanced breast cancer. Results from a phase II studyBreast Cancer Research and Treatment, 1996
- 5-fluorouracil rechallenge by protracted infusion in refractory breast cancerCancer, 1989
- Low-dose continuous infusion 5-fluorouracil. Evaluation in advanced breast carcinomaCancer, 1989
- Optimal schedule for 5-fluorouracil chemotherapyAmerican Journal of Clinical Oncology, 1985